Tradestie Institutional Equity Comparison Engine

MXCT vs TMCI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TMCI Overall Edge

TMCI Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Treace Medical Concepts, Inc. Common Stock (TMCI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus TMCI at N/M Forward P/E and -24.4% operating margin (-3.9% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TMCI sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MXCT N/M vs TMCI N/M Fwd P/E
Growth & Margin Winner TMCI
Op Margin -85.5% vs -24.4% ยท YoY +48.7% vs -3.9%
Momentum & Technical Winner TMCI
1Y -19.4% vs +58.5% ยท 52W Pos 63% vs 74%
Options & Structure Winner TMCI
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (100th %ile IV)
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0
TMCI NASDAQ
Treace Medical Concepts, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$4.31
-0.92% 1D
Market Cap $285.2M
1M Return +0.7%
1Y Return +58.46%
Forward P/E N/M
Unified AI Score
42.7 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MXCT -19.41% TMCI +58.46% Spread: +77.87 pp (TMCI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MXCT Revenue TMCI Revenue MXCT Op. Margin TMCI Op. Margin Margin Edge
FY2019 $10M $40M -93.7% -9.0% TMCI
FY2020 $20M $60M -71.6% 1.5% TMCI
FY2021 $20M $90M -84.3% -17.5% TMCI
FY2022 $30M $140M -95.2% -24.6% TMCI
FY2023 $20M $190M -247.7% -27.5% TMCI
FY2024 $20M $210M -230.5% -26.6% TMCI
FY2025 $20M $210M -247.6% -25.5% TMCI

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MXCT (3) vs TMCI (5)
Institutional Metric MXCT TMCI Criterion Row Winner
Market Capitalization Scale $132.2M $285.2M Larger Scale TMCI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +48.7% -3.9% Higher Growth MXCT
Operating Margin (TTM) Profitability -85.5% -24.4% Higher Margin TMCI
Net Profit Margin Profitability -81.4% -27.4% Higher Margin TMCI
Return on Equity (ROE) Capital Efficiency -16.9% -74.0% Higher ROE MXCT
52-Week Range Position Momentum 63% ($1โ€“$2) 74% ($1โ€“$5) Stronger Trend TMCI
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 96% Vol 2.03ฮฒ ยท 110% Vol Lower Realized Risk MXCT
Unified Institutional Score Composite Signal 41.7 / 100 (SELL) 42.7 / 100 (HOLD) Higher Composite TMCI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MXCT vs TMCI Buy Guide
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TMCI CONSOLIDATION
106d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live TMCI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MXCT nor TMCI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.